Laura Sighinolfi

Laura Sighinolfi

Modena, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications

Prevalence and risk factors of cognitive frailty in people with HIV.

Prevalence and risk factors of cognitive frailty in people with HIV.

Journal: AIDS (London, England)
Published: January 29, 2025

A Machine Learning Approach to Predict Weight Change in ART-Experienced People Living With HIV.

A Machine Learning Approach to Predict Weight Change in ART-Experienced People Living With HIV.

Journal: Journal of acquired immune deficiency syndromes (1999)
Published: November 13, 2022

Patients with HIV and cirrhosis: the risk for hepatocellular carcinoma after direct-acting antivirals for hepatitis C virus.

Patients with HIV and cirrhosis: the risk for hepatocellular carcinoma after direct-acting antivirals for hepatitis C virus.

Journal: AIDS (London, England)
Published: June 08, 2021

Anti-Tat immunity defines CD4+ T-cell dynamics in people living with HIV on long-term cART.

Anti-Tat immunity defines CD4+ T-cell dynamics in people living with HIV on long-term cART.

Journal: EBioMedicine
Published: January 14, 2021

A comparison between different anti-retroviral therapy regimes on soluble inflammation markers: a pilot study.

A comparison between different anti-retroviral therapy regimes on soluble inflammation markers: a pilot study.

Journal: AIDS research and therapy
Published: June 17, 2020

Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy.

Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy.

Journal: Journal of hepatology
Published: June 08, 2020

Statins and aspirin in the prevention of cardiovascular disease among HIV-positive patients between controversies and unmet needs: review of the literature and suggestions for a friendly use.

Statins and aspirin in the prevention of cardiovascular disease among HIV-positive patients between controversies and unmet needs: review of the literature and suggestions for a friendly use.

Journal: AIDS research and therapy
Published: February 08, 2019

Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL.

Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL.

Journal: The Journal of antimicrobial chemotherapy
Published: January 11, 2019

Inflammatory effects of atazanavir/ritonavir versus darunavir/ritonavir in treatment naïve, HIV-1-infected patients.

Inflammatory effects of atazanavir/ritonavir versus darunavir/ritonavir in treatment naïve, HIV-1-infected patients.

Journal: HIV clinical trials
Published: November 14, 2018

Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study.

Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study.

Journal: Frontiers in immunology
Published: October 31, 2018

Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?

Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?

Journal: BMC public health
Published: October 29, 2018

Viro-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >500,000 copies/ml in clinical practice.

Viro-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >500,000 copies/ml in clinical practice.

Journal: Antiviral therapy
Published: September 07, 2017
Showing 1-12 of 45

Last Updated: 09/26/2026